Financials
- Market Capitalization 421.26 M
- Employee 73
- Founded 2005
- CEO Jason Okazaki
- Website www.assemblybio.com
- Headquarter Delaware, United States
- FIGI BBG000R62Q06
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-61.84
Relación precio/flujo de caja
5.27
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2907 | RZLT Rezolute, Inc. - Common Stock | 4.64 USD | -4.72% | +9.18% | +11.00% | -40.89% | 448.79 M USD | ||
| 2918 | YDES YD Bio Limited - Ordinary Shares | 6.18 USD | -2.37% | +13.81% | +54.11% | -66.41% | 437.48 M USD | ||
| 2924 | ENTX Entera Bio Ltd. - Ordinary Shares | 2.49 USD | -6.04% | -3.11% | -11.39% | -2.35% | 431.12 M USD | ||
| 2943 | SLN Silence Therapeutics Plc - American Depository Share | 8.75 USD | -9.33% | -9.61% | -31.96% | +55.69% | 413.41 M USD |